ESMO 2022 Conference Coverage
ESMO 2022 on the Results From the PREVAIL Prospective Cohort Study: Prevalence of PD-L1 High Expression in Advanced Urothelial Carcinoma
By
ESMO 2022 Conference Coverage
FEATURING
Petros Grivas
By
ESMO 2022 Conference Coverage
FEATURING
Petros Grivas
Comments 0
Login to view comments.
Click here to Login
